The RSNA-ASNR-MICCAI BraTS 2021 Benchmark on Brain Tumor Segmentation
and Radiogenomic Classification
- URL: http://arxiv.org/abs/2107.02314v1
- Date: Mon, 5 Jul 2021 23:12:06 GMT
- Title: The RSNA-ASNR-MICCAI BraTS 2021 Benchmark on Brain Tumor Segmentation
and Radiogenomic Classification
- Authors: Ujjwal Baid, Satyam Ghodasara, Michel Bilello, Suyash Mohan, Evan
Calabrese, Errol Colak, Keyvan Farahani, Jayashree Kalpathy-Cramer, Felipe C.
Kitamura, Sarthak Pati, Luciano M. Prevedello, Jeffrey D. Rudie, Chiharu
Sako, Russell T. Shinohara, Timothy Bergquist, Rong Chai, James Eddy, Julia
Elliott, Walter Reade, Thomas Schaffter, Thomas Yu, Jiaxin Zheng, BraTS
Annotators, Christos Davatzikos, John Mongan, Christopher Hess, Soonmee Cha,
Javier Villanueva-Meyer, John B. Freymann, Justin S. Kirby, Benedikt
Wiestler, Priscila Crivellaro, Rivka R.Colen, Aikaterini Kotrotsou, Daniel
Marcus, Mikhail Milchenko, Arash Nazeri, Hassan Fathallah-Shaykh, Roland
Wiest, Andras Jakab, Marc-Andre Weber, Abhishek Mahajan, Bjoern Menze, Adam
E. Flanders, Spyridon Bakas
- Abstract summary: The BraTS 2021 challenge celebrates its 10th anniversary.
It is jointly organized by the Radiological Society of North America (RSNA), the American Society of Neuroradiology (ASNR), and the Medical Image Computing and Computer Assisted Interventions (MICCAI)
- Score: 4.431870223745215
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: The BraTS 2021 challenge celebrates its 10th anniversary and is jointly
organized by the Radiological Society of North America (RSNA), the American
Society of Neuroradiology (ASNR), and the Medical Image Computing and Computer
Assisted Interventions (MICCAI) society. Since its inception, BraTS has been
focusing on being a common benchmarking venue for brain glioma segmentation
algorithms, with well-curated multi-institutional multi-parametric magnetic
resonance imaging (mpMRI) data. Gliomas are the most common primary
malignancies of the central nervous system, with varying degrees of
aggressiveness and prognosis. The RSNA-ASNR-MICCAI BraTS 2021 challenge targets
the evaluation of computational algorithms assessing the same tumor
compartmentalization, as well as the underlying tumor's molecular
characterization, in pre-operative baseline mpMRI data from 2,000 patients.
Specifically, the two tasks that BraTS 2021 focuses on are: a) the segmentation
of the histologically distinct brain tumor sub-regions, and b) the
classification of the tumor's O[6]-methylguanine-DNA methyltransferase (MGMT)
promoter methylation status. The performance evaluation of all participating
algorithms in BraTS 2021 will be conducted through the Sage Bionetworks Synapse
platform (Task 1) and Kaggle (Task 2), concluding in distributing to the top
ranked participants monetary awards of $60,000 collectively.
Related papers
- BraTS-PEDs: Results of the Multi-Consortium International Pediatric Brain Tumor Segmentation Challenge 2023 [44.64458075448]
We present the results of the BraTS-PEDs 2023 challenge, the first Brain Tumor (BraTS) challenge focused on pediatric brain tumors.
BraTS-PEDs 2023 aimed to evaluate volumetric segmentation algorithms for pediatric brain gliomas from magnetic resonance imaging.
The top-performing AI approaches for pediatric tumor analysis included ensembles of nnU-Net and Swin UNETR, Auto3DSeg, or nnU-Net with a self-supervised framework.
arXiv Detail & Related papers (2024-07-11T20:35:32Z) - Brain Tumor Segmentation (BraTS) Challenge 2024: Meningioma Radiotherapy Planning Automated Segmentation [47.119513326344126]
The BraTS-MEN-RT challenge aims to advance automated segmentation algorithms using the largest known multi-institutional dataset of radiotherapy planning brain MRIs.
Each case includes a defaced 3D post-contrast T1-weighted radiotherapy planning MRI in its native acquisition space.
Target volume annotations adhere to established radiotherapy planning protocols.
arXiv Detail & Related papers (2024-05-28T17:25:43Z) - The 2024 Brain Tumor Segmentation (BraTS) Challenge: Glioma Segmentation on Post-treatment MRI [5.725734864357991]
The 2024 Brain Tumor (BraTS) challenge on post-treatment glioma MRI will provide a community standard and benchmark for state-of-the-art automated segmentation models.
Challenge competitors will develop automated segmentation models to predict four distinct tumor sub-regions.
Models will be evaluated on separate validation and test datasets.
arXiv Detail & Related papers (2024-05-28T17:07:55Z) - Analysis of the BraTS 2023 Intracranial Meningioma Segmentation Challenge [44.586530244472655]
We describe the design and results from the BraTS 2023 Intracranial Meningioma Challenge.
The BraTS Meningioma Challenge differed from prior BraTS Glioma challenges in that it focused on meningiomas.
The top ranked team had a lesion-wise median dice similarity coefficient (DSC) of 0.976, 0.976, and 0.964 for enhancing tumor, tumor core, and whole tumor.
arXiv Detail & Related papers (2024-05-16T03:23:57Z) - The Brain Tumor Segmentation (BraTS) Challenge 2023: Focus on Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs) [4.119582963064813]
Pediatric tumors of the central nervous system are the most common cause of cancer-related death in children.
The five-year survival rate for high-grade gliomas in children is less than 20%.
The BraTS-PEDs 2023 challenge focuses on the development of volumentric segmentation algorithms for pediatric brain glioma.
arXiv Detail & Related papers (2023-05-26T15:40:11Z) - HNF-Netv2 for Brain Tumor Segmentation using multi-modal MR Imaging [86.52489226518955]
We extend our HNF-Net to HNF-Netv2 by adding inter-scale and intra-scale semantic discrimination enhancing blocks.
Our method won the RSNA 2021 Brain Tumor AI Challenge Prize (Segmentation Task)
arXiv Detail & Related papers (2022-02-10T06:34:32Z) - Ensemble CNN Networks for GBM Tumors Segmentation using Multi-parametric
MRI [0.0]
We propose a new aggregation of two deep learning frameworks namely, DeepSeg and nnU-Net for automatic glioblastoma recognition in pre-operative mpMRI.
Our ensemble method obtains Dice similarity scores of 92.00, 87.33, and 84.10 and Hausdorff Distances of 3.81, 8.91, and 16.02 for the enhancing tumor, tumor core, and whole tumor regions.
arXiv Detail & Related papers (2021-12-13T10:51:20Z) - H2NF-Net for Brain Tumor Segmentation using Multimodal MR Imaging: 2nd
Place Solution to BraTS Challenge 2020 Segmentation Task [96.49879910148854]
Our H2NF-Net uses the single and cascaded HNF-Nets to segment different brain tumor sub-regions.
We trained and evaluated our model on the Multimodal Brain Tumor Challenge (BraTS) 2020 dataset.
Our method won the second place in the BraTS 2020 challenge segmentation task out of nearly 80 participants.
arXiv Detail & Related papers (2020-12-30T20:44:55Z) - Automatic Brain Tumor Segmentation with Scale Attention Network [1.7767466724342065]
Multimodal Brain Tumor Challenge 2020 (BraTS 2020) provides a common platform for comparing different automatic algorithms on multi-parametric Magnetic Resonance Imaging (mpMRI)
We propose a dynamic scale attention mechanism that incorporates low-level details with high-level semantics from feature maps at different scales.
Our framework was trained using the 369 challenge training cases provided by BraTS 2020, and achieved an average Dice Similarity Coefficient (DSC) of 0.8828, 0.8433 and 0.8177, as well as 95% Hausdorff distance (in millimeter) of 5.2176, 17.9697 and 13.4298 on 166 testing cases for whole tumor
arXiv Detail & Related papers (2020-11-06T04:45:49Z) - Brain tumor segmentation with self-ensembled, deeply-supervised 3D U-net
neural networks: a BraTS 2020 challenge solution [56.17099252139182]
We automate and standardize the task of brain tumor segmentation with U-net like neural networks.
Two independent ensembles of models were trained, and each produced a brain tumor segmentation map.
Our solution achieved a Dice of 0.79, 0.89 and 0.84, as well as Hausdorff 95% of 20.4, 6.7 and 19.5mm on the final test dataset.
arXiv Detail & Related papers (2020-10-30T14:36:10Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.